Loading...
XTAE
EMITF-M
Market cap21mUSD
Apr 29, Last price  
709.40ILS
1D
-4.14%
1Q
-3.68%
Jan 2017
5,302.89%
Name

Elbit Imaging Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
23,998.92
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.18%
Rev. gr., 5y
-30.45%
Revenues
328k
588,623,797816,224,0001,665,605,6503,507,465,6421,098,317,000693,377,0001,473,712,0001,011,298,000671,086,000360,597,000398,578,000347,964,000261,858,000782,829,00000000328,000
Net income
-18m
L+5,733.76%
43,426,88786,884,800559,483,187921,946,379-103,714,000-533,269,00061,998,000-264,919,000-293,590,000-1,155,645,0001,008,999,000-186,150,000-194,830,000-338,034,000-517,833,000-107,497,000229,851,000-20,498,000-311,000-18,143,000
CFO
-3m
L-14.08%
0-99,042,600-521,802,3750220,656,000-754,331,000-334,587,000-240,889,000-148,624,000-16,873,000281,135,000191,353,000158,755,000433,812,000-20,293,000-14,803,000-15,649,000-3,378,000-3,437,000-2,953,000
Dividend
Jun 29, 20230.58332 ILS/sh

Profile

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petach Tikva, Israel.
URL
http://www.elbitimaging.com
IPO date
Nov 01, 1996
Employees
3
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
328
 
Cost of revenue
9,669
1,171
Unusual Expense (Income)
NOPBT
(9,341)
(1,171)
NOPBT Margin
Operating Taxes
52
17
Tax Rate
NOPAT
(9,393)
(1,188)
Net income
(18,143)
5,733.76%
(311)
-98.48%
Dividends
(1,333)
(10,071)
Dividend yield
3.47%
2,641.48%
Proceeds from repurchase of equity
9,333
BB yield
-24.28%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
618
618
Net debt
(39,095)
(33,712)
Cash flow
Cash from operating activities
(2,953)
(3,437)
CAPEX
Cash from investing activities
4,699
23,891
Cash from financing activities
8,000
(10,071)
FCF
(9,393)
(1,188)
Balance
Cash
41,540
32,075
Long term investments
(2,445)
1,637
Excess cash
39,079
33,712
Stockholders' equity
409,688
249,368
Invested Capital
24,213
29,569
ROIC
ROCE
EV
Common stock shares outstanding
9,747
9,143
Price
3.94
9,355.64%
0.04
-29.32%
Market cap
38,432
9,980.29%
381
-29.46%
EV
172,844
153,374
EBITDA
(9,341)
(1,171)
EV/EBITDA
Interest
Interest/NOPBT